Tumor-associated macrophage-derived chemokine ligand 5 regulates the Hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway to promote breast cancer invasion and migration.
{"title":"Tumor-associated macrophage-derived chemokine ligand 5 regulates the Hypoxia-inducible factor-1α/vascular endothelial growth factor signaling pathway to promote breast cancer invasion and migration.","authors":"Yongyun Zhu, Mingxiang Zhang, Zhengzhi Zhu","doi":"10.25259/Cytojournal_6_2025","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Tumor-associated macrophages (TAMs) are important components of the breast cancer (BC) microenvironment that contributes to tumor progression by secreting cytokines. Chemokine ligand 5 (CCL5) expression is upregulated in BC, but the specific mechanism of TAM-derived CCL5 in BC microenvironment remains elucidated. This article aims to explore the role of TAM-derived CCL5 in the progression of BC.</p><p><strong>Material and methods: </strong>M2-type TAMs were induced from Tohoku Hospital Pediatrics-1 (THP-1) monocytes. CCL5 expression in TAM cells was evaluated. The biological effects of recombinant or TAM-derived CCL5 on ZR-75-30 cells were examined using proliferation, migration, invasion assays, and epithelial-mesenchymal transition (EMT) markers. CCL5 was silenced in TAMs and hypoxia-inducible factor-1α (HIF-1α) was overexpressed to explore the downstream signaling pathway.</p><p><strong>Results: </strong>CCL5 expression was significantly increased in TAMs compared with that in BC cells (<i>P</i> < 0.001). Recombinant CCL5 and TAM-conditioned medium promoted ZR-75-30 cell proliferation, migration, and invasion and EMT (<i>P</i> < 0.01), whereas CCL5 knockdown in TAMs markedly reversed these effects (<i>P</i> < 0.001). EMT-related changes, including decreased E-cadherin expression and increased Vimentin, matrix metalloproteinase (MMP)2, and MMP9 expression levels, were reversed by CCL5 silencing (<i>P</i> < 0.01). Inhibition of CCL5 significantly reduced HIF-1α and vascular endothelial growth factor (VEGF) expression levels (<i>P</i> < 0.001), and these reductions were rescued by HIF-1α overexpression (<i>P</i> < 0.01). Functional rescue experiments confirmed that HIF-1α overexpression restored cell proliferation and invasion and EMT suppressed by CCL5 knockdown. Angiogenesis was suppressed by CCL5 silencing and subsequently restored by HIF-1α overexpression (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>TAM-derived CCL5 plays an oncogenic role in BC by regulating HIF-1α/VEGF pathway-mediated malignancy and angiogenesis.</p>","PeriodicalId":49082,"journal":{"name":"Cytojournal","volume":"23 ","pages":"26"},"PeriodicalIF":2.2000,"publicationDate":"2026-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13192363/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cytojournal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25259/Cytojournal_6_2025","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Tumor-associated macrophages (TAMs) are important components of the breast cancer (BC) microenvironment that contributes to tumor progression by secreting cytokines. Chemokine ligand 5 (CCL5) expression is upregulated in BC, but the specific mechanism of TAM-derived CCL5 in BC microenvironment remains elucidated. This article aims to explore the role of TAM-derived CCL5 in the progression of BC.
Material and methods: M2-type TAMs were induced from Tohoku Hospital Pediatrics-1 (THP-1) monocytes. CCL5 expression in TAM cells was evaluated. The biological effects of recombinant or TAM-derived CCL5 on ZR-75-30 cells were examined using proliferation, migration, invasion assays, and epithelial-mesenchymal transition (EMT) markers. CCL5 was silenced in TAMs and hypoxia-inducible factor-1α (HIF-1α) was overexpressed to explore the downstream signaling pathway.
Results: CCL5 expression was significantly increased in TAMs compared with that in BC cells (P < 0.001). Recombinant CCL5 and TAM-conditioned medium promoted ZR-75-30 cell proliferation, migration, and invasion and EMT (P < 0.01), whereas CCL5 knockdown in TAMs markedly reversed these effects (P < 0.001). EMT-related changes, including decreased E-cadherin expression and increased Vimentin, matrix metalloproteinase (MMP)2, and MMP9 expression levels, were reversed by CCL5 silencing (P < 0.01). Inhibition of CCL5 significantly reduced HIF-1α and vascular endothelial growth factor (VEGF) expression levels (P < 0.001), and these reductions were rescued by HIF-1α overexpression (P < 0.01). Functional rescue experiments confirmed that HIF-1α overexpression restored cell proliferation and invasion and EMT suppressed by CCL5 knockdown. Angiogenesis was suppressed by CCL5 silencing and subsequently restored by HIF-1α overexpression (P < 0.001).
Conclusion: TAM-derived CCL5 plays an oncogenic role in BC by regulating HIF-1α/VEGF pathway-mediated malignancy and angiogenesis.
期刊介绍：
The CytoJournal is an open-access peer-reviewed journal committed to publishing high-quality articles in the field of Diagnostic Cytopathology including Molecular aspects. The journal is owned by the Cytopathology Foundation and published by the Scientific Scholar.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
